Literature DB >> 15194013

Head-to-head comparison between contrast-enhanced magnetic resonance imaging and dobutamine magnetic resonance imaging in men with ischemic cardiomyopathy.

Theodorus A M Kaandorp1, Jeroen J Bax, Joanne D Schuijf, Eric P Viergever, Ernst E van Der Wall, Albert de Roos, Hildo J Lamb.   

Abstract

Contrast-enhanced magnetic resonance imaging (MRI) can predict functional recovery after revascularization. Segments with small, subendocardial scars have a large likelihood of recovery, and segments with transmural infarction have a small likelihood of recovery. Segments with an intermediate extent of infarction have an intermediate likelihood of recovery, and therefore, additional information is needed. Accordingly, the transmurality of infarction on contrast-enhanced MRI was compared with low-dose dobutamine MRI to further define viability in 48 patients. Regional contractile dysfunction was determined by cine MRI at rest (17-segment model), and contractile reserve was determined using low-dose dobutamine infusion. Contrast-enhanced MRI was performed to assess the extent of scar tissue. A total of 338 segments (41%) were dysfunctional, with 61% having contractile reserve. Most segments (approximately 75%) with small, subendocardial scars (hyperenhancement scores 1 or 2) had contractile reserve, whereas contractile reserve was not frequently (17%) observed in segments with transmural infarction (hyperenhancement score 4) (p <0.05). Of segments with an intermediate infarct transmurality (hyperenhancement score 3), contractile reserve was observed in 42%, whereas 58% did not have contractile reserve. In conclusion, the agreement between contrast-enhanced MRI and low-dose dobutamine MRI is large in the extremes (subendocardial scars and transmural scars), and contrast-enhanced MRI may be sufficient to assess the likelihood of the recovery of function after revascularization. However, 61% of segments with an intermediate extent of scar tissue on MRI have contractile reserve and 39% lack contractile reserve. In these segments, low-dose dobutamine MRI may be needed to optimally differentiate myocardium with large and small likelihoods of functional recovery after revascularization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194013     DOI: 10.1016/j.amjcard.2004.03.003

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

Review 1.  Cardiovascular MR to access myocardial viability in chronic ischaemic LV dysfunction.

Authors:  T A M Kaandorp; H J Lamb; E E van der Wall; A de Roos; J J Bax
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

Review 2.  MRI of left ventricular function.

Authors:  Frederick H Epstein
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

3.  The Role of Cardiovascular Magnetic Resonance Imaging in Heart Failure.

Authors:  Mark A Peterzan; Oliver J Rider; Lisa J Anderson
Journal:  Card Fail Rev       Date:  2016-11

4.  [Diagnosis and therapy of chronic myocardial ischemia. Role of cardiac magnetic resonance imaging].

Authors:  S de Waha; I Eitel; S Desch; G Fuernau; P Lurz; G Schuler; H Thiele
Journal:  Herz       Date:  2013-06       Impact factor: 1.443

5.  3-Tesla MRI for the evaluation of myocardial viability: a comparative study with 1.5-Tesla MRI.

Authors:  G Ligabue; F Fiocchi; S Ferraresi; A Barbieri; R Rossi; M G Modena; R Romagnoli; P Torricelli
Journal:  Radiol Med       Date:  2008-07-09       Impact factor: 3.469

6.  Rest and low-dose dobutamine Tc-99m-mibi gated-SPECT for early prediction of left ventricular remodeling after a first reperfused myocardial infarction.

Authors:  Laura Ernande; Florent Cachin; Pascal Chabrot; Nicolas Durel; Dominique Morand; Louis Boyer; Jean Maublant; Janusz Lipiecki
Journal:  J Nucl Cardiol       Date:  2009-05-29       Impact factor: 5.952

7.  Cardiac magnetic resonance imaging in patients with coronary disease.

Authors:  Henry D Wu; Raymond Y Kwong
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-02

8.  Chronic total coronary occlusion in patients with intermediate viability: value of low-dose dobutamine and contrast-enhanced 3-T MRI in predicting functional recovery in patients undergoing percutaneous revascularisation with drug-eluting stent.

Authors:  F Fiocchi; F Sgura; A Di Girolamo; G Ligabue; S Ferraresi; R Rossi; R D'Amico; M G Modena; P Torricelli
Journal:  Radiol Med       Date:  2009-06-23       Impact factor: 3.469

Review 9.  The 20 year evolution of dobutamine stress cardiovascular magnetic resonance.

Authors:  Charaslak Charoenpanichkit; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2010-10-26       Impact factor: 5.364

10.  Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischaemic origin: a cardiovascular magnetic resonance study.

Authors:  Christos V Bourantas; Nikolay P Nikitin; Huan P Loh; Elena I Lukaschuk; Nassar Sherwi; Ramesh de Silva; Ann C Tweddel; Mohamed F Alamgir; Kenneth Wong; Sanjay Gupta; Andrew L Clark; John Gf Cleland
Journal:  J Cardiovasc Magn Reson       Date:  2011-09-21       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.